TVGN
ANALYST COVERAGE1 analysts
HOLD
Hold
1100%
0 Buy (0%)1 Hold (100%)0 Sell (0%)
Full report →
Signal
Bearish Setup2
Price
1
Move-15.61%Selling pressure
Volume
1
Volume0.6× avgNormal activity
Technical
1
RSIRSI 49Momentum negative
PRICE
Prev Close
9.42
Open
9.20
Day Range7.95 – 9.41
7.95
9.41
52W Range4.14 – 75.50
4.14
75.50
5% of range
VOLUME & SIZE
Avg Volume
33.0K
FUNDAMENTALS
P/E Ratio
-1.0x
Not profitable
EPS (TTM)
Div Yield
No dividend
Upcoming Events
EEarnings Report
Tomorrow
May 18
DEx-Dividend
In 89 days
Aug 14
PDividend Pay
In 116 days
Sep 10
Key MetricsTTM
Market Cap$33.29M
Revenue TTM$0.00
Net Income TTM-$21.35M
Free Cash Flow-$11.82M
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity241.4%
Return on Assets-433.9%
Debt / Equity-0.31
Current Ratio0.29
EPS TTM$-6.13

TVGN News

About

No description available.

Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Neal FlomenbergChief Scientific Officer and Global R&D Lead
Ryan H. SaadiCo-Founder, Chief Executive Officer & Chairperson
Mittul MehtaChief Information Officer & Head of Tevogen.ai
Tapan V. ShahHead of Investor Relations & Corporate Development
David E. BankoGlobal Head of Government Affairs & Patient Access
Kirti DesaiChief Financial Officer
Sadiq KhanChief Commercial Officer & Interim Head of Tevogen Generics
Stephen ChenChief Technical Officer